Literature DB >> 18512213

Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats.

Claire Bloomfield1, Sarah J French, Declan N C Jones, Charlie Reavill, Eric Southam, Jackie Cilia, Susan Totterdell.   

Abstract

Chandelier neurons are a subset of parvalbumin containing cortical interneurons characterised by their preferential targeting of the axon initial segments of pyramidal neurons. They have been the focus of recent interest after evidence that the arrays of boutons are reduced in the prefrontal cortex of schizophrenic patients, post mortem. Since one chandelier neuron may innervate the axon initial segments of several hundred pyramidal neurons, it is hypothesized that their special connectivity might facilitate synchronisation of cortical outputs and play a key role in working memory. Disruption in their function is therefore thought to play a potentially important role in cortically associated symptoms of schizophrenia. Using the isolation rearing animal model of schizophrenia, we examined immunolabelling for GABA-transporter 1, a marker of chandelier cartridges. We show that the numbers of arrays of chandelier axons are reduced by 36% in the ventral prelimbic cortex of isolation-reared rats, compared with their socially-housed litter mates. This mimics findings in the PFC of schizophrenic patients where GAT-1-positive cartridges are reduced by 40% and is the first study to demonstrate changes in chandelier cartridges in an animal model of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512213     DOI: 10.1002/syn.20521

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  11 in total

1.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

Review 2.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

3.  Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Authors:  Philip L R Gaskin; Stephen P H Alexander; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 4.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Parvalbumin interneuron in the ventral hippocampus functions as a discriminator in social memory.

Authors:  Xiaofei Deng; Lijia Gu; Nan Sui; Jianyou Guo; Jing Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

6.  Prefrontal Cortex GABAergic Deficits and Circuit Dysfunction in the Pathophysiology and Treatment of Chronic Stress and Depression.

Authors:  Sriparna Ghosal; Brendan Hare; Ronald S Duman
Journal:  Curr Opin Behav Sci       Date:  2017-04

Review 7.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

8.  In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.

Authors:  Antonio Napolitano; Khalid Shah; Mirjam I Schubert; Veronica Porkess; Kevin C F Fone; Dorothee P Auer
Journal:  Schizophr Bull       Date:  2013-05-13       Impact factor: 9.306

9.  The impact of adolescent social isolation on dopamine D2 and cannabinoid CB1 receptors in the adult rat prefrontal cortex.

Authors:  M L Fitzgerald; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

10.  Anhedonic behavior and γ-amino butyric acid during a sensitive period in female rats exposed to early adversity.

Authors:  Jodi L Lukkes; Shirisha Meda; Kevin J Norman; Susan L Andersen
Journal:  J Psychiatr Res       Date:  2018-02-13       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.